About this position
Glioblastomas (GBM) are the most common and aggressive primary brain tumors in humans. Immunotherapies, which revolutionized the treatment of systemic tumors, remain inefficient for GBM, most likely due to a high immunosuppressive environment. Tumor-associated macrophages (TAMs), the major immune...
Members only · Free to join
Sign in to see the full opening
Get the entry requirements, funding, the supervisor's contact and a link to the original advert.
- How to apply
- Contact details
Free forever No credit card 30-second sign-up
